Company’s 36-month beta value is 1.19.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for RZLT is 45.42M, and currently, short sellers hold a 2.91% ratio of that floaft. The average trading volume of RZLT on September 02, 2024 was 427.62K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RZLT) stock’s latest price update
Rezolute Inc (NASDAQ: RZLT) has seen a rise in its stock price by 0.21 in relation to its previous close of 4.75. However, the company has experienced a 10.70% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-08-05 that Second rare disease program with RZ358 in Phase 3 development Follows successful treatment of multiple patients with tumor hyperinsulinism under the Company’s Expanded Access Program REDWOOD CITY, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for its Investigational New Drug (IND) application for RZ358 (ersodetug) to treat hypoglycemia in patients with tumor hyperinsulinism (HI).
RZLT’s Market Performance
RZLT’s stock has risen by 10.70% in the past week, with a monthly rise of 7.94% and a quarterly rise of 18.11%. The volatility ratio for the week is 5.52% while the volatility levels for the last 30 days are 5.93% for Rezolute Inc The simple moving average for the last 20 days is 8.54% for RZLT stock, with a simple moving average of 82.38% for the last 200 days.
Analysts’ Opinion of RZLT
Many brokerage firms have already submitted their reports for RZLT stocks, with Guggenheim repeating the rating for RZLT by listing it as a “Buy.” The predicted price for RZLT in the upcoming period, according to Guggenheim is $11 based on the research report published on August 27, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see RZLT reach a price target of $13. The rating they have provided for RZLT stocks is “Buy” according to the report published on July 17th, 2024.
Craig Hallum gave a rating of “Buy” to RZLT, setting the target price at $14 in the report published on June 04th of the current year.
RZLT Trading at 8.70% from the 50-Day Moving Average
After a stumble in the market that brought RZLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.97% of loss for the given period.
Volatility was left at 5.93%, however, over the last 30 days, the volatility rate increased by 5.52%, as shares surge +10.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.26% upper at present.
During the last 5 trading sessions, RZLT rose by +10.70%, which changed the moving average for the period of 200-days by +458.03% in comparison to the 20-day moving average, which settled at $4.41. In addition, Rezolute Inc saw 379.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RZLT starting from Hogenhuis Wladimir, who purchase 4,815 shares at the price of $4.15 back on Jun 25 ’24. After this action, Hogenhuis Wladimir now owns 37,508 shares of Rezolute Inc, valued at $19,982 using the latest closing price.
ROBERTS BRIAN KENNETH, the Chief Medical Officer of Rezolute Inc, purchase 4,300 shares at $3.91 during a trade that took place back on Jun 14 ’24, which means that ROBERTS BRIAN KENNETH is holding 54,352 shares at $16,828 based on the most recent closing price.
Stock Fundamentals for RZLT
The total capital return value is set at -0.76. Equity return is now at value -58.75, with -52.46 for asset returns.
Based on Rezolute Inc (RZLT), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -21.17. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -22.86.
Currently, EBITDA for the company is -51.75 million with net debt to EBITDA at 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.82.
Conclusion
In a nutshell, Rezolute Inc (RZLT) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
